RedHill Says New Crohns Treatment May Reduce Side Effects
Israeli company RedHill Biopharma reports its experimental Crohn's treatment RHB-204 matches prior effectiveness with reduced ingredients for fewer side.
Crohn’s Disease
Biotech Firm Amorphical Reports Breakthrough in Crohn’s Disease Therapy
Israeli biotech Amorphical announces breakthrough Crohn’s therapy, achieving sustained remission with nano-amorphous Calcium Carbonate in Phase 2 trial at.
Navigation